Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial.

IH, Dilogo; D, Aditianingsih; A, Sugiarto; E, Burhan; T, Damayanti; PA, Sitompul; N, Mariana; RD, Antarianto; IK, Liem; T, Kispa; F, Mujadid; N, Novialdi; E, Luviah; T, Kurniawati; AMT, Lubis; D, Rahmatika

doi:10.1002/sctm.21-0046

Public

Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial.

Shared by NobleBlocks on Jun 8, 2021 • 12:00 AM UTC

Authors:

Dilogo IH

Aditianingsih D

Sugiarto A

Abstract

One of the main causes of acute respiratory distress syndrome in coronavirus disease 2019 (COVID-19) is cytokine storm, although the exact cause is still unknown. Umbilical cord mesenchymal stromal cells (UC-MSCs) influence proinflammatory T-helper 2 (Th<sub>2</sub> ) cells to shift to an anti-infla...

Subject

Adjuvants

immunology

Mesenchymal Stromal Cells

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!